Who is sponsoring NCT05141864?

NCT05141864 is sponsored by Universidade do Vale do Sapucai.

What drugs are being tested in NCT05141864?

Interventions in NCT05141864: Acmella oleracea gel, Lidocaine 2 % Topical Cream, Ultrasound gel.

What condition does NCT05141864 study?

NCT05141864 studies Analgesia in the Digital Rectal Examination.

Is NCT05141864 still recruiting?

NCT05141864 is currently completed. Last updated 2 December 2021.

Last reviewed 2021-12-02 · How we verify

NCT05141864

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acmella Oleracea in the Analgesia of the Digital Rectal Examination

Completed Phase 1 Last updated 2 December 2021

What this trial tests

Phase 1 trial testing Acmella oleracea gel in Analgesia in the Digital Rectal Examination in 150 participants. Completed in 5 November 2021.

Timeline

5 March 2021

Primary endpoint
5 June 2021

5 November 2021

Quick facts

Lead sponsor	Universidade do Vale do Sapucai
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	150
Start date	5 March 2021
Primary completion	5 June 2021
Estimated completion	5 November 2021
Sites	1 location across Brazil

Drugs / interventions tested

Acmella oleracea gel — full drug profile →
Lidocaine 2 % Topical Cream — full drug profile →
Ultrasound gel

Conditions studied

Analgesia in the Digital Rectal Examination — all drugs for Analgesia in the Digital Rectal Examination →

Sponsor

Universidade do Vale do Sapucai — full company profile →

Who can join

Adults 45 to 80, male only, with Analgesia in the Digital Rectal Examination. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to develop an herbal gel based on Acmella oleracea and do a comparative analysis to evaluate the intensity of pain during the digital rectal examination comparing to lidocaine gel group and ultrasound gel group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Universidade do Vale do Sapucai trials

Trials by the same sponsor.

NCT06427733 — Green Banana Peel Extract for Stasis Dermatitis Treatment · Phase 1 · completed
NCT05031689 — Green Banana Peel Extract for Melasma Treatment · Phase 1 · completed
NCT05252117 — Uterovaginal Plexus Block With Articaine for Intrauterine Device Placement Patients Who Are Indicated for the Use of Cop · Phase 4 · unknown
NCT04696224 — Comparative Use of Tranexamic Acid Intravenous and Topical Application in Intertrochanteric Fractures With PFNA · NA · unknown
NCT04698811 — Virtual Eneagram: Quality of Life, Stress and Anxiety. · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05141864 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidade do Vale do Sapucai
Last refreshed: 2 December 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05141864.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing